Clinical trial
Pilot Study to Investigate the Effect of Tadalafil on Secondary Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
NCT00506701 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study to Investigate the Effect of Tadalafil on Secondary Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
- Lead sponsor
- Herlev Hospital
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- February 29, 2008
- Completion date
- February 28, 2010
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive lung disease